181 related articles for article (PubMed ID: 18344057)
1. Clinical heterogeneity in newly diagnosed Parkinson's disease.
Post B; Speelman JD; de Haan RJ;
J Neurol; 2008 May; 255(5):716-22. PubMed ID: 18344057
[TBL] [Abstract][Full Text] [Related]
2. Anxiety disorders in Parkinson's disease: prevalence and risk factors.
Dissanayaka NN; Sellbach A; Matheson S; O'Sullivan JD; Silburn PA; Byrne GJ; Marsh R; Mellick GD
Mov Disord; 2010 May; 25(7):838-45. PubMed ID: 20461800
[TBL] [Abstract][Full Text] [Related]
3. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015): an ongoing global Parkinson's disease project about disease progression with more than 1000 subjects included. Results from the baseline evaluation.
Santos García D; Jesús S; Aguilar M; Planellas LL; García Caldentey J; Caballol N; Legarda I; Hernández Vara J; Cabo I; López Manzanares L; González Aramburu I; Ávila Rivera MA; Catalán MJ; López Díaz L; Puente V; García Moreno JM; Borrué C; Solano Vila B; Álvarez Sauco M; Vela L; Escalante S; Cubo E; Carrillo Padilla F; Martínez Castrillo JC; Sánchez Alonso P; Alonso Losada MG; López Ariztegui N; Gastón I; Kulisevsky J; Menéndez González M; Seijo M; Rúiz Martínez J; Valero C; Kurtis M; de Fábregues-Boixar O; González Ardura J; Prieto Jurczynska C; Martinez-Martin P; Mir P;
Eur J Neurol; 2019 Nov; 26(11):1399-1407. PubMed ID: 31179586
[TBL] [Abstract][Full Text] [Related]
4. Comparison of age of onset and development of motor complications between smokers and non-smokers in Parkinson's disease.
De Reuck J; De Weweire M; Van Maele G; Santens P
J Neurol Sci; 2005 Apr; 231(1-2):35-9. PubMed ID: 15792818
[TBL] [Abstract][Full Text] [Related]
5. Systematic review of factors associated with depression and anxiety disorders among older adults with Parkinson's disease.
Sagna A; Gallo JJ; Pontone GM
Parkinsonism Relat Disord; 2014 Jul; 20(7):708-15. PubMed ID: 24780824
[TBL] [Abstract][Full Text] [Related]
6. Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson's disease.
Riedel O; Klotsche J; Spottke A; Deuschl G; Förstl H; Henn F; Heuser I; Oertel W; Reichmann H; Riederer P; Trenkwalder C; Dodel R; Wittchen HU
J Neurol; 2010 Jul; 257(7):1073-82. PubMed ID: 20140443
[TBL] [Abstract][Full Text] [Related]
7. Preliminary examination of the comorbidity of anxiety and depression in Parkinson's disease.
Henderson R; Kurlan R; Kersun JM; Como P
J Neuropsychiatry Clin Neurosci; 1992; 4(3):257-64. PubMed ID: 1498578
[TBL] [Abstract][Full Text] [Related]
8. Progression of motor impairment and disability in Parkinson disease: a population-based study.
Alves G; Wentzel-Larsen T; Aarsland D; Larsen JP
Neurology; 2005 Nov; 65(9):1436-41. PubMed ID: 16275832
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with depression in Parkinson's disease.
Dissanayaka NN; Sellbach A; Silburn PA; O'Sullivan JD; Marsh R; Mellick GD
J Affect Disord; 2011 Jul; 132(1-2):82-8. PubMed ID: 21356559
[TBL] [Abstract][Full Text] [Related]
10. The heterogeneity of cognitive symptoms in Parkinson's disease: a meta-analysis.
Tremblay C; Achim AM; Macoir J; Monetta L
J Neurol Neurosurg Psychiatry; 2013 Nov; 84(11):1265-72. PubMed ID: 23606738
[TBL] [Abstract][Full Text] [Related]
11. Cognitive phenotypes in Parkinson's disease: A latent profile analysis.
Barvas E; Mattavelli G; Zappini F; Giardina F; Ottaviani D; Papagno C
Neuropsychology; 2021 May; 35(4):451-459. PubMed ID: 34043394
[TBL] [Abstract][Full Text] [Related]
12. Nonmotor symptoms in nursing home residents with Parkinson's disease: prevalence and effect on quality of life.
Weerkamp NJ; Tissingh G; Poels PJ; Zuidema SU; Munneke M; Koopmans RT; Bloem BR
J Am Geriatr Soc; 2013 Oct; 61(10):1714-21. PubMed ID: 24117286
[TBL] [Abstract][Full Text] [Related]
13. Clinical problems in non-fluctuating patients with Parkinson's disease: a community-based study.
Larsen JP; Karlsen K; Tandberg E
Mov Disord; 2000 Sep; 15(5):826-9. PubMed ID: 11009186
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors of motor impairment, disability, and quality of life in newly diagnosed PD.
Velseboer DC; Broeders M; Post B; van Geloven N; Speelman JD; Schmand B; de Haan RJ; de Bie RM;
Neurology; 2013 Feb; 80(7):627-33. PubMed ID: 23345637
[TBL] [Abstract][Full Text] [Related]
15. The association between Parkinson's disease symptom side-of-onset and performance on the MDS-UPDRS scale part IV: Motor complications.
Bay AA; Hart AR; Michael Caudle W; Corcos DM; Hackney ME
J Neurol Sci; 2019 Jan; 396():262-265. PubMed ID: 30537631
[TBL] [Abstract][Full Text] [Related]
16. The effect of depression on motor function and disease severity of Parkinson's disease.
Papapetropoulos S; Ellul J; Argyriou AA; Chroni E; Lekka NP
Clin Neurol Neurosurg; 2006 Jul; 108(5):465-9. PubMed ID: 16150537
[TBL] [Abstract][Full Text] [Related]
17. Differential progression of motor impairment in levodopa-treated Parkinson's disease.
Goetz CG; Stebbins GT; Blasucci LM
Mov Disord; 2000 May; 15(3):479-84. PubMed ID: 10830412
[TBL] [Abstract][Full Text] [Related]
18. A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease.
Starkstein SE; Mayberg HS; Leiguarda R; Preziosi TJ; Robinson RG
J Neurol Neurosurg Psychiatry; 1992 May; 55(5):377-82. PubMed ID: 1602311
[TBL] [Abstract][Full Text] [Related]
19. Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study.
Shiba M; Bower JH; Maraganore DM; McDonnell SK; Peterson BJ; Ahlskog JE; Schaid DJ; Rocca WA
Mov Disord; 2000 Jul; 15(4):669-77. PubMed ID: 10928577
[TBL] [Abstract][Full Text] [Related]
20. Does the MDS-UPDRS provide the precision to assess progression in early Parkinson's disease? Learnings from the Parkinson's progression marker initiative cohort.
Regnault A; Boroojerdi B; Meunier J; Bani M; Morel T; Cano S
J Neurol; 2019 Aug; 266(8):1927-1936. PubMed ID: 31073716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
